Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial-Reference-Cited by-同舟云学术

Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial

Published:2021-10 Issue: Volume:187 Page:106574
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Inoue Yoshikazu^ORCID,Suda Takafumi,Kitamura Hideya,Okamoto Masaki^ORCID,Azuma Arata,Inase Naohiko,Kuwana Masataka,Makino Shigeki^ORCID,Nishioka Yasuhiko,Ogura Takashi,Takizawa Ayako^ORCID,Ugai Hiroyuki,Stowasser Susanne,Schlenker-Herceg Rozsa,Takeuchi Tsutomu

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference36 articles.

1. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases;Cottin;Eur. Respir. Rev.,2018

2. The natural history of progressive fibrosing interstitial lung diseases;Kolb;Respir. Res.,2019

3. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management;Wijsenbeek;Curr. Med. Res. Opin.,2019

4. Nintedanib for systemic sclerosis-associated interstitial lung disease;Distler;N. Engl. J. Med.,2019

5. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases;Fischer;Clin. Rheumatol.,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD;Heart & Lung;2024-11

2. The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial;Respiratory Investigation;2024-07

3. Progressive pulmonary fibrosis associated autoimmune diseases: Systematic review of the literature;Revista Colombiana de Reumatología (English Edition);2024-04

4. Progressive pulmonary fibrosis associated autoimmune diseases: Systematic review of the literature;Revista Colombiana de Reumatología;2023-11

5. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report;Modern Rheumatology Case Reports;2023-04-15